ARCHIVES

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | March 20, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Pharmacia Corp. Forms $1 Million Fund To Support Anthracycline Research.

June 2, 2000

Einhorn Begins Term; Salmon, Blum Honored; Gore Gives Award To IntraMall, Piloted At NCI.

May 26, 2000

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

ACS Research Grants Hit $78.2 Million

July 18, 1986

FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations

August 14, 1992